CD8+ T cells are the main effector cells to kill tumor cells, while activated CD4+ T cells can significantly increase the cellular components of innate immunity, such as macrophages and NK cells, by increasing the secretion of IFN-γ (Veatch et al., 2022). This evidence concerns the gene CD8A and neoplasm.